National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Hodgkin Lymphoma Survivors Have Increased Lifetime Risk of Solid Cancers
    Posted: 04/20/2007
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Related Pages
Hodgkin Lymphoma Home Page
NCI's gateway for information about Hodgkin lymphoma.

Coping with Cancer
Managing side effects and complications caused by cancer and its treatment.

Adapted from the NCI Cancer Bulletin, vol. 4/no. 13, March 27, 2007 (see the current issue).

Survivors of Hodgkin lymphoma (HL) likely have a significantly increased risk of solid cancers throughout their lives, according to a new study that analyzed several variables influencing risk in this patient population. Results from the international study, published online March 19, 2007, in the Journal of Clinical Oncology, give estimates of risk that can help in risk assessment and screening plans for survivors.

Investigators used data from 18,862 people with HL who had survived for at least five years after diagnosis, collected from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) database as well as from four European registries. Variables used in the risk model included sex, year of HL diagnosis, age at HL diagnosis, initial treatment received, and age at diagnosis of solid cancer.

Of the 1,490 solid cancers that were identified, approximately 850 were estimated to be in excess. The risk of developing a solid cancer depended on age at diagnosis of HL, attained age, and sex, with women diagnosed at young ages having the highest risk. The patterns of risk differed between types of solid cancer and the most common sites for excess cancer were the female breast, lungs, and colorectum.

For both colorectal and breast cancers, young HL survivors had absolute risks comparable to those observed in the general population in the age ranges in which screening would normally be recommended (age 50 and above for colorectal screening, age 40 and above for mammography), suggesting that HL survivors would benefit from earlier routine screening.

"This is the first study to quantify the cumulative sex-specific risk of solid cancer for specific ages at Hodgkin lymphoma diagnosis," explains Dr. Ethel Gilbert, from NCI's Division of Cancer Epidemiology and Genetics, one of the authors of the study. "For current survivors, there is a need to investigate interventions to reduce the morbidity and mortality caused by second cancers," conclude the authors.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov